Back to Farallon Capital Management, L.L.C. Farallon Capital Management, L.L.C.

NVAXNVAX

Showing 8 of 17 quarters

Position history for Farallon Capital Management, L.L.C.Farallon Capital Management, L.L.C.'s holdings in Novavax, Inc.

No. Farallon Capital Management exited its NVAX (Novavax) position in Q2 2026. Its Q1 2026 13F listed 22,000 shares worth $179,080. Farallon Capital Management first reported NVAX in Q4 2020 and held it in 14 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$202,080

Total Shares Change

-16,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$9.42
0
2026-Q1
Decreased
22,000
-88.7%
$179,0800.0%$8.14
0
2025-Q4
Decreased
195,000
-75.0%
$1.3M0.0%$6.72
0
2025-Q3
Increased
780,000
+4775.0%
$6.8M0.0%$8.67
44
2025-Q2
Unchanged
16,000
0.0%
$100,8000.0%$6.30
0
2025-Q1
Unchanged
16,000
0.0%
$102,5600.0%$6.41
0
2024-Q4
Unchanged
16,000
0.0%
$128,6400.0%$8.04
0
2024-Q3
Decreased
16,000
-95.8%
$202,0800.0%$12.63
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used